Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Plans Three Risk Management-Related Guidances Under PDUFA III

Executive Summary

FDA's PDUFA III implementation plan will likely include three separate guidances to cover risk assessment, pharmacovigilance and risk management

You may also be interested in...



Drug Names Will Be Reviewed By FDA Within 90 Days Under PDUFA Timetable

FDA is establishing timetables for review of proprietary drug names as part of the next cycle of the Prescription Drug User Fee Act

Drug Names Will Be Reviewed By FDA Within 90 Days Under PDUFA Timetable

FDA is establishing timetables for review of proprietary drug names as part of the next cycle of the Prescription Drug User Fee Act

PhRMA Wary Of Large Simple Safety Trials, Tells FDA Not To Create Phase III+

Large simple safety studies should not become a routine pre-approval requirement, the Pharmaceutical Research & Manufacturers of America suggested during FDA's risk management public workshop April 9

Related Content

UsernamePublicRestriction

Register

PS040081

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel